Publications

Hogan Lovells Publications

Understanding sunshine rules: how new transparency regulations in Europe are changing relationships between industry and health care professionals

The 2010 Physician Payments Sunshine Act created a new standard of transparency for financial relationships between pharmaceutical companies and health care professionals in the U.S. Now,...

Hogan Lovells Publications

New Jersey issues rules to chill drug manufacturer payments to prescribers

The New Jersey Attorney General plans to finalize new limits on payments and other benefits that New Jersey licensed prescribers may accept from pharmaceutical manufacturers, although the...

Hogan Lovells Publications

New California law limits drug manufacturer co-pay cards and other discounts in California

In the most recent salvo by states eager to show an effort to contain prescription drug costs, California's governor has signed into law a bill that will prohibit, with some limited...

Hogan Lovells Publications

A path forward: Corporate Integrity Agreement sheds light on manufacturer interactions with independent charitable foundations

Manufacturers of pharmaceuticals and biologics have been closely watching the industry-wide investigation by the Boston U.S. Attorney's Office into manufacturer support of independent...

Hogan Lovells Publications

New Jersey joins wave of states proposing new rules for drug marketing and HCP interactions

Drug manufacturers are once again facing new state limits on marketing and interactions with healthcare providers. Manufacturers should review the new laws and regulations carefully,...

Hogan Lovells Publications

To the spoiler go the spoils: OIG approves limited product replacement program

A perennial question for manufacturers of drugs and biologicals that require specialized handling, storage, or reconstitution is how to handle circumstances in which the product is spoiled, ...

Hogan Lovells Publications

HHS OIG Finalizes New Exclusion Rules as Administration Exits

With just a week left before a new administration takes office, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) finalized changes to the regulations ...

;
Loading data